Usefulness of FTA® cards as a Pneumocystis-DNA extraction method in bronchoalveolar lavage samples

被引:4
作者
Rodino, Jenniffer M. [1 ]
Aguilar, Yudy A. [1 ,2 ]
Vanessa Rueda, Zulma [3 ]
Velez, Lazaro A. [1 ,4 ]
机构
[1] Univ Antioquia, Grp Invest Problemas Enfermedades Infecciosas GRI, Fac Med, Medellin, Colombia
[2] Univ Antioquia, Corp Ciencias Basicas Biomed, Medellin, Colombia
[3] Univ Pontificia Bolivariana, Fac Med, Medellin, Colombia
[4] Univ Antioquia, Fac Med, Secc Enfermedades Infecciosas, Medellin, Colombia
关键词
affinity chromatography; bronchoalveolar lavage; Pneumocystis jirovecii; polymerase chain reaction; FTA (R); REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; NUCLEIC-ACID AMPLIFICATION; HIV-INFECTED PATIENTS; FILTER-PAPER; IMMUNOCOMPROMISED PATIENTS; MOLECULAR CHARACTERIZATION; DIRECT IMMUNOFLUORESCENCE; RESPIRATORY SPECIMENS; TEMPLATE PREPARATION;
D O I
10.3109/23744235.2015.1129550
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background FTA (R) cards (Fast Technology for Analysis of Nucleic Acids) are an alternative DNA extraction method in bronchoalveolar lavage (BAL) samples for Pneumocystis jirovecii molecular analyses. The goal was to evaluate the usefulness of FTA (R) cards to detect P. jirovecii-DNA by PCR in BAL samples compared to silica adsorption chromatography (SAC). Methods This study used 134 BAL samples from immunocompromised patients previously studied to establish microbiological aetiology of pneumonia, among them 15 cases of Pneumocystis pneumonia (PCP) documented by staining and 119 with other alternative diagnoses. The FTA (R) system and SAC were used for DNA extraction and then amplified by nested PCR to detect P. jirovecii. Performance and concordance of the two DNA extraction methods compared to P. jirovecii microscopy were calculated. The influence of the macroscopic characteristics, transportation of samples and the duration of the FTA (R) card storage (1, 7, 10 or 12 months) were also evaluated. Results Among 134 BAL samples, 56% were positive for P. jirovecii-DNA by SAC and 27% by FTA (R). All 15 diagnosed by microscopy were detected by FTA (R) and SAC. Specificity of the FTA (R) system and SAC were 82.4% and 49.6%, respectively. Compared to SAC, positivity by FTA (R) decreased with the presence of blood in BAL (62% vs 13.5%). The agreement between samples at 7, 10 and 12 months was 92.5% for FTA (R). Positive cases by FTA (R) remained the same after shipment by mail. Conclusions Results suggest that FTA (R) is a practical, safe and economical method to preserve P. jirovecii-DNA in BAL samples for molecular studies.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 35 条
[21]   Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: An international collaborative quality control study among 30 laboratories [J].
Noordhoek, GT ;
vanEmbden, JDA ;
Kolk, AHJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) :2522-2525
[22]   Flinders Technology Associates (FTA) filter paper-based DNA extraction with polymerase chain reaction (PCR) for detection of Pneumocystis jirovecii from respiratory specimens of Immunocompromised patients [J].
Nuchprayoon, Surang ;
Saksirisampant, Wilai ;
Jaijakul, Siraya ;
Nuchpirayoon, Issarang .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2007, 21 (06) :382-386
[23]  
Orlandi PA, 2000, J CLIN MICROBIOL, V38, P2271
[24]   Use of filter paper (FTA®) technology for sampling, recovery and molecular characterisation of rabies viruses [J].
Picard-Meyer, E. ;
Barrat, J. ;
Cliquet, E. .
JOURNAL OF VIROLOGICAL METHODS, 2007, 140 (1-2) :174-182
[25]  
QIAGEN, 2010, QIACARD FTA HDB
[26]  
Rodiño J, 2011, BIOMEDICA, V31, P222, DOI 10.1590/S0120-41572011000200010
[27]   Comparison of the FXG™: RESP (Asp plus ) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens [J].
Seah, Christine ;
Richardson, Susan E. ;
Tsui, George ;
Yu, Billy ;
Thornback, John ;
McTaggart, Lisa ;
Boggild, Andrea ;
Wengenack, Nancy L. ;
Zhang, Sean X. .
MEDICAL MYCOLOGY, 2012, 50 (03) :324-327
[28]  
Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4
[29]  
Tasaka S, 2015, CLIN MED INSIGHTS-CI, V9, P19, DOI [10.4137/CCRPRPM.S23324, 10.4137/CCRPM.S23324]
[30]   Pneumocystis pneumonia [J].
Thomas, CF ;
Limper, AH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (24) :2487-2498